Simplex Trading’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-171
| Closed | -$71K | – | 10162 |
|
|
2025
Q3 | $71K | Buy |
+171
| New | +$57.5K | ﹤0.01% | 6116 |
|
|
2024
Q2 | – | Sell |
-7,660
| Closed | -$2.03M | – | 9897 |
|
|
2024
Q1 | $1.76M | Buy |
7,660
+6,218
| +431% | +$1.4M | ﹤0.01% | 2534 |
|
|
2023
Q4 | $317K | Buy |
+1,442
| New | +$332K | ﹤0.01% | 4168 |
|
|
2023
Q2 | – | Sell |
-6,374
| Closed | -$1.41M | – | 10010 |
|
|
2023
Q1 | $1.43M | Buy |
+6,374
| New | +$1.57M | ﹤0.01% | 2243 |
|
|
2021
Q2 | – | Sell |
-8,668
| Closed | -$1.65M | – | 10749 |
|
|
2021
Q1 | $0 | Buy |
8,668
+6,517
| +303% | +$1.09M | ﹤0.01% | 10119 |
|
|
2020
Q4 | $326K | Buy |
+2,151
| New | +$282K | ﹤0.01% | 3964 |
|
|
2020
Q3 | – | Sell |
-3,064
| Closed | -$336K | – | 8571 |
|
|
2020
Q2 | $370K | Buy |
+3,064
| New | +$345K | ﹤0.01% | 3272 |
|
|
2020
Q1 | – | Sell |
-1,707
| Closed | -$162K | – | 8333 |
|
|
2019
Q4 | $150K | Buy |
+1,707
| New | +$150K | ﹤0.01% | 4064 |
|
|
2019
Q2 | – | Sell |
-3,038
| Closed | -$284K | – | 7841 |
|
|
2019
Q1 | $356K | Buy |
+3,038
| New | +$354K | ﹤0.01% | 3021 |
|
|
2018
Q4 | – | Sell |
-6,027
| Closed | -$699K | – | 7876 |
|
|
2018
Q3 | $770K | Sell |
6,027
-28
| -0.5% | -$3.46K | ﹤0.01% | 2153 |
|
|
2018
Q2 | $685K | Buy |
+6,055
| New | +$666K | ﹤0.01% | 2153 |
|
|
2018
Q1 | – | Sell |
-12,372
| Closed | -$1.57M | – | 6914 |
|
|
2017
Q4 | $1.83M | Buy |
12,372
+5,405
| +78% | +$687K | 0.08% | 206 |
|
|
2017
Q3 | $816K | Sell |
6,967
-626
| -8% | -$79.9K | 0.03% | 447 |
|
|
2017
Q2 | $985K | Buy |
+7,593
| New | +$947K | 0.04% | 369 |
|
|
2017
Q1 | – | Sell |
-8,307
| Closed | -$1.26M | – | 6824 |
|
|
2016
Q4 | $1.19M | Buy |
+8,307
| New | +$1.06M | 0.07% | 240 |
|
|
2016
Q2 | – | Sell |
-1,044
| Closed | -$116K | – | 6493 |
|
|
2016
Q1 | $116K | Buy |
+1,044
| New | +$132K | 0.01% | 1234 |
|
|
2015
Q4 | – | Sell |
-2,051
| Closed | -$299K | – | 6187 |
|
|
2015
Q3 | $269K | Buy |
2,051
+1,473
| +255% | +$236K | 0.02% | 746 |
|
|
2015
Q2 | $100K | Buy |
578
+301
| +109% | +$54.1K | 0.01% | 1207 |
|
|
2015
Q1 | $47K | Buy |
+277
| New | +$42.2K | 0.01% | 1613 |
|
Other funds holding UTHR
ACA
VPM
VCM
Simplex Trading's UTHR Position: Q4 2025 in Review
Simplex Trading sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 171 shares — an estimated $71K sold.
Simplex Trading first reported a position in UTHR in Q1 2015 and held it in 19 quarters. The position peaked at $1.83M in Q4 2017. 837 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.
- Simplex Trading reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 171 United Therapeutics shares in Q4 2025, an estimated $71K.
- Simplex Trading first reported a position in United Therapeutics in Q1 2015 and held it in 19 quarters.
- Simplex Trading's United Therapeutics position peaked at $1.83M in Q4 2017.
- 837 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.